Literature DB >> 352707

Effect of clonidine on sympathetic nervous activity in hydralazine-treated hypertensive patients.

M Velasco, H Bertoncini, E Romero, A Urbina-Quintana, J Guevara, O Hernández-Pieretti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 352707     DOI： 10.1007/BF00644601

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  11 in total

1.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

2.  Effect of clonidine on sympathetic nervous activity in hydralazine-treated hypertensive patients.

Authors:  M Velasco; H Bertoncini; E Romero; A Urbina-Quintana; J Guevara; O Hernández-Pieretti
Journal:  Eur J Clin Pharmacol       Date:  1978-07-30       Impact factor: 2.953

Review 3.  Vasodilator drugs in the treatment of hypertension.

Authors:  J Koch-Weser
Journal:  Arch Intern Med       Date:  1974-06

4.  Differential effects of propranolol on heart rate and plasma renin activity in patients treated with minoxidil.

Authors:  M Velasco; K O'Malley; N W Robie; J Wells; Z H Israili; J L McNay
Journal:  Clin Pharmacol Ther       Date:  1974-12       Impact factor: 6.875

5.  [On the mechanism of action of a new antihypertensive substance with imidazoline structure].

Authors:  W Kobinger
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1967

6.  Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade.

Authors:  R Zacest; E Gilmore; J Koch-Weser
Journal:  N Engl J Med       Date:  1972-03-23       Impact factor: 91.245

7.  Minoxidil--an alternative to nephrectomy for refractory hypertension.

Authors:  W A Pettinger; H C Mitchell
Journal:  N Engl J Med       Date:  1973-07-26       Impact factor: 91.245

8.  Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: a comparison with hydralazine.

Authors:  M Velasco; C A Gilbert; C O Rutledge; J L McNay
Journal:  Clin Pharmacol Ther       Date:  1975-08       Impact factor: 6.875

9.  Combined clonidine and hydralazine therapy in severe and refractory hypertension.

Authors:  M Velasco; J Guevara; A Urbina-Quintana; O Hernández-Pieretti
Journal:  Acta Cient Venez       Date:  1977

10.  Mechanism of the interaction of propranolol and a potent vasodilator antihypertensive agent - minoxidil.

Authors:  K O'Malley; M Velasco; J Wells; J McNay
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953
View more
  4 in total

1.  Effect of clonidine on sympathetic nervous activity in hydralazine-treated hypertensive patients.

Authors:  M Velasco; H Bertoncini; E Romero; A Urbina-Quintana; J Guevara; O Hernández-Pieretti
Journal:  Eur J Clin Pharmacol       Date:  1978-07-30       Impact factor: 2.953

2.  Respiratory, metabolic and hemodynamic effects of clonidine in ventilated patients presenting with withdrawal syndrome.

Authors:  Domniki Liatsi; Basilis Tsapas; Smaro Pampori; Matthew Tsagourias; Ioannis Pneumatikos; Dimitrios Matamis
Journal:  Intensive Care Med       Date:  2008-08-16       Impact factor: 17.440

3.  Effect of minoxidil on sympathetic nervous activity in clonidine-treated hypertensive patients.

Authors:  M Velasco; A Urbina-Quintana; E Hernández; A Ramírez; R Aliendres; J Morillo; O Hernández-Pieretti
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

4.  Systemic and cardiac haemodynamic interactions between guanfacine and hydrallazine in hypertensive patients.

Authors:  M Velasco; A Urbina-Quintana; J Morillo; H Vizcarrondo; A Ramirez; E Hernández; O Hernández-Pieretti
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.